RICE HALL JAMES & ASSOCIATES, LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 188 filers reported holding REPLIGEN CORP in Q3 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
RICE HALL JAMES & ASSOCIATES, LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2018$1,762,000
-27.5%
31,775
-38.5%
0.06%
-28.4%
Q2 2018$2,430,000
+28.8%
51,651
-1.0%
0.09%
+18.9%
Q1 2018$1,887,000
-18.0%
52,151
-17.7%
0.07%
-17.8%
Q4 2017$2,300,000
-10.6%
63,383
-5.6%
0.09%
-21.1%
Q3 2017$2,574,000
-7.8%
67,159
-0.3%
0.11%
-5.8%
Q2 2017$2,792,000
+11.5%
67,372
-5.3%
0.12%
-0.8%
Q1 2017$2,504,000
+11.5%
71,136
-2.3%
0.12%
+8.0%
Q4 2016$2,245,000
+1.3%
72,836
-0.8%
0.11%
-2.6%
Q3 2016$2,217,000
+10.0%
73,436
-0.3%
0.12%0.0%
Q2 2016$2,015,000
-0.3%
73,636
-2.3%
0.12%
-0.9%
Q1 2016$2,022,000
-5.0%
75,408
+0.3%
0.12%
-4.1%
Q4 2015$2,128,000
+0.7%
75,208
-0.9%
0.12%
-10.9%
Q3 2015$2,114,000
-31.5%
75,908
+1.5%
0.14%
-23.0%
Q2 2015$3,087,000
+35.2%
74,808
-0.6%
0.18%
+34.8%
Q1 2015$2,284,000
-9.4%
75,227
-40.9%
0.13%
-13.7%
Q4 2014$2,522,000
-1.0%
127,386
-0.5%
0.15%
-14.0%
Q3 2014$2,548,000
-47.5%
127,985
-39.9%
0.18%
-45.4%
Q2 2014$4,851,000
+75.8%
212,851
-0.8%
0.33%
+60.6%
Q1 2014$2,760,000
-28.4%
214,625
-24.1%
0.20%
-27.0%
Q4 2013$3,856,000
+17.2%
282,731
-4.7%
0.28%
-12.0%
Q3 2013$3,289,000
+34.4%
296,531
-0.2%
0.32%
+31.1%
Q2 2013$2,448,000297,1310.24%
Other shareholders
REPLIGEN CORP shareholders Q3 2015
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders